Samsung Biologics signed a 92.7 billion won CMO contract with MSD

Reporter Kim Jisun / approved : 2024-03-13 03:58:11
  • -
  • +
  • 인쇄

Samsung Biologics. (Photo = Samsung Biologics)

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Samsung BioLogics said in a public announcement on the 12th that it has signed a KRW 92.7 billion consignment production contract with global pharmaceutical company MSD Switzerland. This is equivalent to 3.09% of sales as of 2022.

The contract period can be changed according to the agreement between the two companies until December 31, 2032.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years2025.11.07
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations2025.11.07
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom2025.11.07
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking2025.11.07
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally2025.11.07
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사